Bullboard - Stock Discussion Forum Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

Add To Watchlist

GREY:TBPMQ - Post Discussion

Tetra Bio Pharma Inc > The termination of the ATM Program Canaccord

View:

Post by SamV21 on Nov 04, 2021 9:32pm

The termination of the ATM Program Canaccord

today the termination of its previously announced "at-the-market" equity offering program (the "ATM Program") with Canaccord Genuity Corp. as sole agent.

The termination of the ATM Program is effective as of November 11, 2021. Tetra will not be using the ATM Program. The ATM Program was established on May 28, 2021, allowing the Company to issue and sell up to $10 million aggregate amount of common shares of the Company to the public from time to time, at the Company's discretion. As of the date of this announcement, Tetra had not sold any of its common shares under the ATM Program

150

Comment

Comment by Craiger02 on Nov 04, 2021 9:45pm

this could be a very good thing or it could be nothing. Very possible that news coming shortly.

113

Comment

Comment by Golddetector on Nov 04, 2021 10:42pm

Even if they have financing why they need to cancel this? And why they need to announce it? We might hear something soon. Maybe tomorrow morning. Let's see.

Comment